🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II, single-center, open-label study will evaluate the comparable...
Status
Completed
Location
Baylor University Medical Center
Start Date
2017-12-04
Trial ID
NCT03373227
Treatments Being Tested
Antibody mediated rejection (ABMR) is a major cause of graft loss after kid...
Status
Not Yet Recruiting
Location
CHU de ROUEN
Start Date
2026-07-01
Trial ID
NCT06291103
Treatments Being Tested
This study will evaluate the safety, tolerability, and efficacy of Orca-T, ...
Status
Active Not Recruiting
Location
City of Hope
Start Date
2022-06-21
Trial ID
NCT05316701
Treatments Being Tested
This study will enroll individuals who have: * Completed primary series of...
Status
Completed
Location
University of California, San Diego
Start Date
2021-12-06
Trial ID
NCT05077254
This study is being done to investigate the impact of changing immunosuppre...
Status
Completed
Location
Northwestern Memorial Hospital
Start Date
2007-06
Trial ID
NCT00866879
This study is being done to investigate the impact of changing immunosuppre...
Status
Completed
Location
Northwestern University, The Comprehensive Transplant Center
Start Date
2014-07
Trial ID
NCT02213068
Treatments Being Tested
The objective of this trial is to assess the efficacy and safety of aerosol...
Status
Completed
Location
Banner Health
Start Date
2019-03-26
Trial ID
NCT03657342
Treatments Being Tested
The purpose of this study is to evaluate the safety and effectiveness of an...
Status
Withdrawn
Location
University of Wiscsonsin Hospital and Clinics
Start Date
2014-09-24
Trial ID
NCT02130817
The purpose of this study was to assess the efficacy of the bleselumab regi...
Status
Completed
Location
University of Arizona
Start Date
2017-05-22
Trial ID
NCT02921789
The aim of this study is to evaluate the safety and efficacy of lulizumab, ...
Status
Withdrawn
Location
Emory University Hospital
Start Date
2022-01-10
Trial ID
NCT04903054
Treatments Being Tested